Table 5.
Nrf2 Inducer | Animals (Sex, Strain) | Dose (mg/kg), Route of Administration | Mechanism of Action | Reference |
---|---|---|---|---|
Sciatic nerve crush (SNC) injury | ||||
Isoquercitrin | Male ICR mice | 20 mg/kg/day, i.p. 40 to 320 μM isoquercitrin on primary Schwann cells isolated from sciatic nerves of neonatal 1-day-old Sprague Dawley rats—in vitro |
Nrf2 pathway | [139] |
Curcumin | Male Sprague Dawley rats | 0.2 mg/day, continuous delivery through mini-osmotic pumps | Nrf2 pathway | [140] |
Sesame oil | Male SPF C57BL/6 mice | 0.5, 1 and 2 mL/kg, oral | Nrf2 pathway | [141] |
Partial sciatic nerve ligation (PSNL) | ||||
ECN | Male albino mice | 1 and 5 mg/kg, i.p. | Nrf2/HO-1/NQO1 pathway | [142] |
Spared nerve injury (SNI) | ||||
tBHQ | Male Sprague Dawley rats | 1 and 10 μM, i.t. | Nrf2 pathway | [143] |
Dimethyl fumarate | Male Sprague Dawley rats and male and female wild type and Nfe2l2−/− mice | 30, 100, and 300 5 mL−1 kg−1, oral | Nrf2 pathway | [144] |
Sulforaphane | Male Sprague Dawley rats | 30 mg/kg, i.p. | Keap1-Nrf2 signaling | [145] |
Spinal nerve ligation (SNL) | ||||
Dimethylitaconate | Male C57BL/6 mice | 10 mg or 20 mg, i.p. 250 µM on BV2 microglial cell line |
Nrf2 pathway | [146] |
Note. Table is organized based on the most recent to oldest publications.